LitAlert ~~ GeneLit.com

    • Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants.
    • Bernstein-Molho R, Friedman E, Kedar I, Laitman Y, Allweis TM, Gal-Yam EN, Baris Feldman , Grinshpun A, Halpern N, Hartmajer S, Kadouri L, Katz LH, Kaufman B, Laish I, Levanon K, Litz Philipsborn S, Ludman M, Moran G, Peretz T, Reinstein E, Reznick Levi G, Safra T, Shkedi S, Vinkler C, Levy Z, Goldberg Y.
    • Breast Cancer Res Treat. 2020 Apr 18. doi: 10.1007/s10549-020-05633-2. [Epub ahead of print]
    • Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults.
    • Sutherland N, Espinel W, Grotzke M, Colonna S.
    • J Genet Couns. 2020 Apr 18. doi: 10.1002/jgc4.1278. [Epub ahead of print]
    • The uptake of predictive DNA testing in 40 families with a pathogenic BRCA1/BRCA2 variant. An evaluation of the proband-mediated procedure.
    • Menko FH, Jeanson KN, Bleiker EMA, van Tiggelen CWM, Hogervorst FBL, Ter Stege JA, Ait Moha D, van der Kolk LE.
    • Eur J Hum Genet. 2020 Apr 16. doi: 10.1038/s41431-020-0618-8. [Epub ahead of print]
    • Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls.
    • Behl S, Hamel N, de Ladurantaye M, Lepage S, Lapointe R, Mes-Masson AM, Foulkes WD.
    • Sci Rep. 2020 Apr 16;10(1):6491. doi: 10.1038/s41598-020-63100-w.
    • Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets.
    • Fang CB, Wu HT, Zhang ML, Liu J, Zhang GJ.
    • Front Cell Dev Biol. 2020 Apr 2;8:160. doi: 10.3389/fcell.2020.00160. eCollection 2020.